Mitochondrial dysfunction induced by callyspongiolide promotes autophagy-dependent cell death.


Journal

BMB reports
ISSN: 1976-670X
Titre abrégé: BMB Rep
Pays: Korea (South)
ID NLM: 101465334

Informations de publication

Date de publication:
04 2021
Historique:
received: 05 03 2020
pubmed: 2 4 2021
medline: 27 10 2021
entrez: 1 4 2021
Statut: ppublish

Résumé

Callyspongiolide is a marine macrolide known to induce caspaseindependent cancer cell death. While its toxic effects have been known, the mechanism leading to cell death is yet to be identified. We report that Callyspongiolide R form at C-21 (cally2R) causes mitochondrial dysfunction by inhibiting mitochondrial complex I or II, leading to a disruption of mitochondrial membrane potential and a deprivation of cellular energy. Subsequently, we observed, using electron microscopy, a drastic formation of autophagosome and mitophagy. Supporting these data, LC3, an autophagosome marker, was shown to co-localize with LAMP2, a lysosomal protein, showing autolysosome formation. RNA sequencing results indicated the induction of hypoxia and blocking of EGF-dependent pathways, which could be caused by induction of autophagy. Furthermore, mTOR and AKT pathways preventing autophagy were repressed while AMPK was upregulated, supporting autophagosome progress. Finally, the combination of cally2R with known anti-cancer drugs, such as gefitinib, sorafenib, and rapamycin, led to synergistic cell death, implicating potential therapeutic applications of callyspongiolide for future treatments. [BMB Reports 2021; 54(4): 227-232].

Identifiants

pubmed: 33792534
pii: 5323
pmc: PMC8093938

Substances chimiques

Macrolides 0
callyspongiolide 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-232

Références

Cell. 2016 Jul 28;166(3):555-566
pubmed: 27471965
J Nat Prod. 2020 Nov 25;83(11):3381-3386
pubmed: 33151675
Science. 2016 Jan 15;351(6270):275-281
pubmed: 26816379
Oncogene. 2004 Apr 12;23(16):2934-49
pubmed: 15077155
J Biol Chem. 2004 Sep 24;279(39):40670-6
pubmed: 15292229
Am J Cancer Res. 2015 Apr 15;5(5):1844-53
pubmed: 26175952
Arch Biochem Biophys. 2021 Jan 15;697:108688
pubmed: 33227289
Methods Enzymol. 2009;452:181-97
pubmed: 19200883
J Exp Clin Cancer Res. 2018 Mar 20;37(1):63
pubmed: 29554968
Cancer Lett. 2015 Jan 28;356(2 Pt A):165-70
pubmed: 24486219
Cell Metab. 2016 Feb 9;23(2):229-30
pubmed: 26863485
Org Lett. 2014 Jan 3;16(1):266-9
pubmed: 24329175
Cancer Commun (Lond). 2018 Jul 27;38(1):50
pubmed: 30053908
Turk J Gastroenterol. 2018 May;29(3):270-282
pubmed: 29755011
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Physiol Rev. 1999 Oct;79(4):1127-55
pubmed: 10508231
Adv Exp Med Biol. 2020;1207:663-679
pubmed: 32671784
J Am Chem Soc. 2018 Jan 31;140(4):1280-1284
pubmed: 29332397
J Biol Chem. 2000 Nov 17;275(46):35863-7
pubmed: 10961998
Autophagy. 2016 Jul 2;12(7):1206-7
pubmed: 27097231
Cancers (Basel). 2019 Sep 22;11(10):
pubmed: 31546746
Biology (Basel). 2019 Oct 29;8(4):
pubmed: 31671879

Auteurs

Soohyun Lee (S)

pH Pharma Co., Ltd., Seongnam 13494, Korea.
Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea.

Yoonjeong Jeong (Y)

pH Pharma Co., Ltd., Seongnam 13494, Korea.

Jae-Seok Roe (JS)

Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea.

Hoyoung Huh (H)

pH Pharma Co., Ltd., Seongnam 13494, Korea.

Sang Hoon Paik (SH)

pH Pharma Co., Ltd., Seongnam 13494, Korea.

Jaewhan Song (J)

pH Pharma Co., Ltd., Seongnam 13494, Korea.
Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH